Riverview Capital Advisers, LLC Astrazeneca PLC Call Options Transaction History
Riverview Capital Advisers, LLC
- $291 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AZN
# of Institutions
1,349Shares Held
489MCall Options Held
5MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.21 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.72 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.63 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.38 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.25 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $201B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...